Fifty-third Board Meeting

<p>Based on the recommendation of the Audit and Finance Committee (AFC), including their acknowledgement of the Asset-Liability Management presented to the AFC, the Board approves the following:</p> <ol type="i"> <li>the 2026 Work Plan and Budget Narrative, as set forth in GF/B53/ER13A; and</li> <li>the 2026 Operating Expenses Budget in the amount of US$310.3 million, which includes US$13,173,773 for the Office of the Inspector General’s 2026 Operating Expenses, US$3,747,154 for the Ethics Office’s 2026 Operating Expenses, US$2,858,734 for the Evaluation Function’s 2026 Operating Expenses, and US$2,700,000 for the Technical Review Panel’s Operating Expenses, US$1,398,238 for the Constituency Funding 2026 Operating Expenses, as set forth in GF/B53/ER13A.</li> </ol>

<p>The Board approves the appointment of:</p> <ol> <li>Jeremy FARRAR, representing the World Health Organization, as a non-voting<br>member of the Strategy Committee for a term that will expire in May 2028, or<br>until the appointment of his successor.</li> </ol>

<p>The Board approves the appointment of Jennifer Kates to serve as the Vice-Chair of the Ethics and Governance Committee (the “EGC”), effective from the date of approval of this decision and for a term concurrent with the term of the committee as set out in decision point GF/B52/EDP10 or until the appointment of her successor.</p>

<ol> <li>Based on the recommendation of the Chair and Vice-Chair of the Board (the “Board Leadership”), in consultation with the Ethics and Governance Committee (the “EGC”), the Board: <ol type="a"> <li>Notes its responsibilities with regard to the recruitment process of the Executive Director as set out in Article 36 of the Operating Procedures of the Board and Committees of the Global Fund to Fight AIDS, Tuberculosis and Malaria (“BCOP”);</li> <li>Notes the consultations of the Board Leadership and the EGC in relation to this process, including with respect to the establishment of the nomination committee referred to in the BCOP; and</li> <li>Approves the terms of reference of the Executive Director Nomination Committee, as set out in Annex 1 of GF/B53/ER07.</li> </ol> </li> <li>The Board requests the Board Leadership to submit a Chair, Vice-Chair and the membership of the nomination committee to the Board for approval.</li> </ol>

<p>Based on the recommendation of the Ethics and Governance Committee, the Board:</p> <ol> <li>Approves the Amendments to the Terms of Reference of the Ethics Officer, as set forth in Annex 1 to GF/B53/ER06; and</li> <li>Acknowledges with thanks the service of the incumbent Ethics Officer and her continued support to the mission of the Global Fund through the newly established dual-role.&nbsp;</li> </ol>

<p>The Board approves the Report of the 53rd Board Meeting, as set forth in GF/B53/ER05.</p>

<ol> <li>Based on the recommendations of the Board Leadership, the Board approves the appointment of Ms. Sujin Chan-Allen to serve as non-voting independent Member of the Ethics and Governance Committee (the “EGC”),</li> <li>The Board notes that the independent committee member appointed under this decision point shall begin her term at the date of approval of this decision and serve for a term concurrent with the term of the committee as set out in GF/B52/EDP10 or until the appointment of her successor. The independent committee member term is renewable once.</li> </ol>

<ol> <li>The Board notes the recommendation of the Strategy Committee as set forth in GF/SC27/EDP01 and approves the revised Terms of Reference of the Technical Review Panel as set forth in Annex 1 to GF/B53/07, which shall have effect as of the date of this decision.</li> </ol>

<p>Dereck Springer from the Latin America and Caribbean constituency is designated as Rapporteur for the 53rd Board Meeting.</p>

<p>The Agenda for the 53rd Board Meeting (GF/B53/01) is approved.</p>